Key result
Early reinstitution of anticoagulation (24-48 hours) and supratherapeutic levels in the postoperative period increased the frequency of bleeding complications in neurosurgical patients.
Why the study?
What is the optimal timing for initiating or discontinuing anticoagulation in neurosurgical patients to minimize bleeding and thromboembolic risks?
Population
Neurosurgical patients with clear indications for anticoagulation therapy (postoperative or posthemorrhage)
Design
Systematic_review
Authors
Loading...
Caution against resuming anticoagulation within 48 h or at supratherapeutic levels after neurosurgery; confirms individualized, risk-stratified timing.
Systematic Review
What is the optimal timing for initiating or discontinuing anticoagulation in neurosurgical patients to minimize bleeding and thromboembolic risks?
Reintroduction of anticoagulation after neurosurgery should be guided by the patient's specific thromboembolic risk, avoiding early (24-48h) and supratherapeutic administration to minimize bleeding.
Lazio et al. (1999) conducted a systematic review in Neurosurgical patients requiring anticoagulation. Anticoagulation management was evaluated on Postoperative bleeding and thromboembolic complications. Early reinstitution of anticoagulation (24-48 hours) and supratherapeutic levels in the postoperative period increased the frequency of bleeding complications in neurosurgical patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: